null

Filed a patent for "methods of treating systemic lupus erythematosus using btk inhibitors" on Fri, May 19, 2023

Filed a patent for "pyrrolo[2, 3-b]pyrazine-based bifunctional compounds as hpk1 degraders and the use thereof" on Thu, July 11, 2024

Filed a patent for "anti-gpc3 and anti-cd137 multispecific antibodies and methods of use" on Thu, June 27, 2024

Filed a patent for "methods of treating dlbcl using btk inhibitors and combinations thereof" on Thu, March 23, 2023

Filed a patent for "methods of improving progression-free survival with zanubrutinib" on Sun, November 13, 2022

Filed a patent for "methods of treating b-cell malignancy with zanubrutinib in patients intolerant to other btk inhibitors" on Sun, November 13, 2022

Filed a patent for "methods of treating chronic lymphocytic leukemia/small lymphocytic lymphoma" on Wed, November 23, 2022

Filed a patent for "methods of treating b-cell proliferative disorder" on Thu, January 19, 2023

Filed a patent for "oral capsule and preparation method therefor" on Thu, May 18, 2023

Filed a patent for "compositions comprising (s)-7-(1-acryloylpiperidin-4-yl)-2-(4-phenoxyphenyl)-4,5,6,7-tetra-hydropyrazolo[1,5-a]pyrimidine-3-carboxamide" on Thu, August 3, 2023

Filed a patent for "anti-pd1 antibodies and their use as therapeutics and diagnostics" on Thu, September 28, 2023

Filed a patent for "use of a combination comprising a btk inhibitor for treating cancers" on Thu, November 16, 2023

Filed a patent for "methods of treating b-cell proliferative disorder" on Thu, December 21, 2023

Filed a patent for "methods of treating b-cell proliferative disorder" on Thu, December 14, 2023

Filed a patent for "degradation of bruton's tyrosine kinase (btk) by conjugation of btk inhibitors with e3 ligase ligand and method of use" on Thu, June 29, 2023

Filed a patent for "bridged compounds as kras g12d inhibitor and degrader and the use thereof" on Thu, March 21, 2024

Filed a patent for "bridged compounds as kras g12d inhibitor and degrader and the use thereof" on Thu, May 2, 2024

Filed a patent for "kras g12c inhibitors" on Thu, May 23, 2024

Filed a patent for "methods of cancer treatment using anti-tigit antibodies in combination with anti-pd1 antibodies" on Thu, December 7, 2023

Filed a patent for "combinations of a b-raf inhibitor and an anti-egfr antibody for the treatment of cancer" on Mon, July 24, 2023

Filed a patent for "methods of treating chronic active antibody-mediated rejection using btk inhibitors" on Thu, May 2, 2024

Filed a patent for "egfr degraders and methods of use" on Thu, May 23, 2024

Filed a patent for "treatment of indolent or aggressive b-cell lymphomas using a combination comprising btk inhibitors" on Thu, January 11, 2024

Filed a patent for "anti-tim-3 antibodies and use thereof" on Thu, March 7, 2024

Filed a patent for "crystalline form of (s)-7-(1-acryloylpiperidin-4-yl)-2-(4-phenoxyphenyl)-4,5,6,7-tetra-hydropyrazolo[1,5-a]pyrimidine-3-carboxamide, preparation, and uses thereof" on Thu, February 22, 2024